Category: Press Release - Page 167 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Ehave, Inc. Partners with Cognitive Apps to Add Artificial Intelligence-Powered Mental Health Analytical Platform for Psychedelic Use in G20 Countries

Ehave, Inc. Partners with Cognitive Apps to Add Artificial Intelligence-Powered Mental Health Analytical Platform for Psychedelic Use in G20 Countries

Post published:January 7, 2021
Post category:Press Release

Read more about the article Ontario Brain Institute Increases Investment in Diamond Therapeutics to Accelerate Innovation in Mental Health

Ontario Brain Institute Increases Investment in Diamond Therapeutics to Accelerate Innovation in Mental Health

Post published:January 7, 2021
Post category:Press Release

Read more about the article Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing

Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing

Post published:January 7, 2021
Post category:Press Release

Read more about the article MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand

MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand

Post published:January 7, 2021
Post category:Press Release

Read more about the article Red Light Holland Announces $5 Million Bought Deal Equity Financing

Red Light Holland Announces $5 Million Bought Deal Equity Financing

Post published:January 7, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Shares Intellectual Property Update

Mydecine Innovations Group Shares Intellectual Property Update

Post published:January 7, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders

Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders

Post published:January 7, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory Board

Tryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory Board

Post published:January 7, 2021
Post category:Press Release

Read more about the article NeonMind Appoints Trevor Millar as Chief Psychedelic Officer

NeonMind Appoints Trevor Millar as Chief Psychedelic Officer

Post published:January 7, 2021
Post category:Press Release

Read more about the article CYBIN Provides Update on Patent Filings & Development of Therapeutics Program

CYBIN Provides Update on Patent Filings & Development of Therapeutics Program

Post published:January 6, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.